Asthenic syndrome in the convalescents of ixodid tick-borne borrelioses
- Authors: Kulagina A.P.1, Suzdaltsev A.A.1
-
Affiliations:
- Samara State Medical University
- Issue: Vol 23, No 1 (2023)
- Pages: 10-14
- Section: INFECTIOUS DISEASES
- URL: https://bakhtiniada.ru/2410-3764/article/view/126186
- DOI: https://doi.org/10.55531/2072-2354.2023.23.1.10-14
- ID: 126186
Cite item
Full Text
Abstract
Aim – to study the catamnesis of patients with ixodid tick-borne borreliosis in the period of convalescence who presented the signs of asthenic syndrome.
Material and methods. The study was based on the data of prospective dispensary observation of 37 in-patients diagnosed with "ixodid tick-borne borreliosis, erythemic form, moderate severity, acute course" who received treatment at the Clinic of Infectious Diseases of the SamSMU in 2016-2019. The subjects were divided into 3 groups according to their age: the first age-group from 18 to 35 years included 12 people, the second group ranged from 36 to 55 years and included 15 people, the third age-group from 56 to 75 years consisted of 10 people. The examination of patients was carried out after discharge from the hospital on the 14th day, after 3, 12 and 36 months. The MFI-20 asthenia scale (the Multidimensional Fatigue Inventory) was used to analyze the asthenic syndrome in the participants.
Results. The duration of asthenia after ixodid tick-borne borreliosis may be up to 3 years. Patients require the closest observation in the first 2 weeks of the convalescence period. Indicators of physical and psychological health in convalescents return to the norm depending on their age and place of residence. Mental asthenia prevails in people living in rural areas and persists much longer than in urban residents. Older people (from 56 to 75 years) are more susceptible to general and physical asthenia.
Full Text
##article.viewOnOriginalSite##About the authors
Anastasiya P. Kulagina
Samara State Medical University
Author for correspondence.
Email: a.p.kulagina@samsmu.ru
ORCID iD: 0000-0003-2422-4925
Assistant of the Department of Infectious Diseases with Epidemiology, Infectious Disease Physician of the Specialized Consultative and Diagnostic Center of the SamSMU Clinics
Russian Federation, SamaraAleksei A. Suzdaltsev
Samara State Medical University
Email: infect.samgmu@mail.ru
ORCID iD: 0000-0002-4688-1910
PhD, Professor, Professor of the Department of Infectious Diseases with Epidemiology
Russian Federation, SamaraReferences
- Lobzin YuV, Uskov AN, Kozlov SS. Lime-borreliosis (ixodic tick-borne borreliosis). SPb, 2000. (In Russ.). [Лобзин Ю.В., Усков А.Н., Козлов С.С. Лайм-боррелиоз (иксодовые клещевые боррелиозы). СПб., 2000].
- Solovey NV, Shcherba VV, Karpov IA, et al. The consequences of tick-borne borreliosis: myths and reality from the standpoint of evidence-based medicine. Infectious diseases. 2013;11(2):55-63. (In Russ.). [Соловей Н.В., Щерба В.В., Карпов И.А., и др. Последствия перенесенного клещевого боррелиоза: мифы и реальность с позиций доказательной медицины. Инфекционные болезни. 2013;11(2):55-63].
- Sumlivaya ON, Vorobyeva NN, Karakulova YuV. Postinfection syndrome in convalescents of ixodic tick-borne borrelioses. Journal of Infectology. 2014;6(4):27-32. (In Russ.). [Сумливая О.Н., Воробьева Н.Н., Каракулова Ю.В. Постинфекционный синдром у реконвалесцентов иксодовых клещевых боррелиозов. Журнал инфектологии. 2014;6(4):27-32].
- Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a metaanalysis of reported symptoms. Int J Epidemiol. 2005;34(6):1340-1345. doi: 10.1093/ije/dyi129
- Ścieszka J, Dąbek J, Cieślik P. Post-Lyme disease syndrome. Reumatologia. 2015;53(1):46-8. doi: 10.5114/reum.2015.5055117
- Aucott JN, Rebman AW, Crowder LA, Kortte KB. Posttreatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res. 2013;22(1):75-84. doi: 10.1007/s11136-012-0126-6
- Wills AB, Spaulding AB, Adjemian J, et al. Long-term follow-up of patients with Lyme disease: longitudinal analysis of clinical and quality-of-life measures. Clin Infect Dis. 2016;62(12):1546-1551. doi: 10.1093/cid/ciw189
- Błaut-Jurkowska J, Jurkowski M. Zespół poboreliozowy. Pol Merkur Lekarski. 2016;40(236):129-33.
- Aucott JN. Posttreatment Lyme disease syndrome. Infect Dis Clin North Am. 2015;29(2):309-23. doi: 10.1016/j.idc.2015.02.012
- van den Wijngaard CC, Hofhuis A, Harms MG, et al. The burden of Lyme borreliosis expressed in disabilityadjusted life years. Eur J Public Health. 2015;25(6):1071-1078. doi: 10.1093/eurpub/ckv091
- Moniuszko A, Czupryna P, Zajkowska J, et al. Zespół post Lyme jako problem kliniczny. Pol Merkur Lekarski. 2009;26(153):227-30.
- Błaut-Jurkowska J, Jurkowski M. Zespół poboreliozowy. Pol Merkur Lekarski. 2016;40(236):129-33.
- Wong KH, Shapiro ED, Soffer GK. A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist. Clin Rev Allergy Immunol. 2022;62(1):264-271. doi: 10.1007/s12016-021-08906-w
- Vrijmoeth HD, Ursinus J, Harms MG, et al. Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect). BMC Infect Dis. 2019;19(1):324. doi: 10.1186/s12879-019-3949-8
Supplementary files
